Literature DB >> 10147458

Ionizing radiation and the retina.

D B Archer1, T A Gardiner.   

Abstract

This review considers the effects of ionizing radiation on the retina and examines the relationship between the natural course of radiation retinopathy and the radiobiology of the retinal vascular endothelial cell (RVEC). Radiation retinopathy presents clinically as a progressive pattern of degenerative and proliferative vascular changes, chiefly affecting the macula, and ranging from capillary occlusion, dilation, and microaneurysm formation, to telangiectasia, intraretinal microvascular abnormalities, and neovascularization. The total-radiation dose and fractionation schedule are the major determinants for the time of onset, rate of progression, and severity of retinopathy, although other factors such as concomitant chemotherapy and preexisting diabetes may exaggerate the vasculopathy by intensifying the oxygen-derived free-radical assault on the vascular cells. The differential radiosensitivity of RVECs is attributed to their nuclear chromatin conformation, their antioxidant status, and their environment. We propose pathogenetic mechanisms for radiation retinopathy and suggest that the peculiar latency and unique clinical pattern is related to the life cycle of the RVEC. A rationale is also proposed for the use of radiotherapy in the treatment of subneovascularization and age-related macular degeneration.

Entities:  

Mesh:

Year:  1994        PMID: 10147458     DOI: 10.1097/00055735-199406000-00011

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  18 in total

1.  [Vitreous hemorrhage and macular edema with loss of vision].

Authors:  C W Spraul; G E Lang
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

2.  [In Process Citation].

Authors: 
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

3.  Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma.

Authors:  B Jurklies; G Anastassiou; S Ortmans; A Schüler; H Schilling; U Schmidt-Erfurth; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Epimacular brachytherapy - old ghost or new age?

Authors:  Norbert Bornfeld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-20       Impact factor: 3.117

Review 5.  [Adjuvant radiotherapy during anti-VEGF in neovascular age-related macular degeneration].

Authors:  P Rating; M-A Freimuth; M Stuschke; N Bornfeld
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

6.  Radiation retinopathy treated successfully with aflibercept.

Authors:  Pakinee Pooprasert; Tafadzwa Young-Zvandasara; Ayad Al-Bermani
Journal:  BMJ Case Rep       Date:  2017-11-09

7.  Proceedings of the 2019 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Mark F Cesta; Torrie A Crabbs; Kyathanahalli S Janardhan; Gregory A Krane; Debabrata Mahapatra; Erin M Quist; Matthias Rinke; George W Schaaf; Gregory S Travlos; Haoan Wang; Cynthia J Willson; Jeffrey C Wolf
Journal:  Toxicol Pathol       Date:  2019-10-23       Impact factor: 1.902

8.  Long-term (4 years) results of choroidal hemangioma treated with proton beam irradiation.

Authors:  A Zeisberg; I Seibel; D Cordini; N Lakotka; G Willerding; L Moser; J Heufelder; A M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-29       Impact factor: 3.117

9.  Reactive Retinal Astrocytic Tumor (Focal Nodular Gliosis): Report of the Clinical Spectrum of 3 Cases.

Authors:  Arun D Singh; Hansell Soto; Claudine Bellerive; Charles V Biscotti
Journal:  Ocul Oncol Pathol       Date:  2017-03-23

Review 10.  Effects of radiotherapy on uveal melanomas and adjacent tissues.

Authors:  C Groenewald; L Konstantinidis; B Damato
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.